Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.
about
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosisRibosome-Inactivating Proteins from Plants: A Historical OverviewH-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors.Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.Induction of proliferation and differentiation of neoplastic B cells by anti-immunoglobulin and T-cell factorsHuman trophoblast cell-surface antigens defined by monoclonal antibodiesSelective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.Antibodies to RNA from autoimmune NZB/NZW mice recognize a similar antigenic determinant and show a large idiotypic diversity.Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugatesMutant monoclonal antibodies with alterations in biological functionsT cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal miceTherapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.Immunotherapeutic strategies to target prognostic and predictive markers of cancer.Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignanciesDifferential agglutination by soybean agglutinin of human leukemia and neuroblastoma cell lines: potential application to autologous bone marrow transplantationMonoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growthChallenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models.Immunotoxins: a review of their use in cancer treatment.Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells.Clinical targeting recombinant immunotoxins for cancer therapySelective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.Targeting of drugs to cell surface receptors.BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution.Intraventricular immunotoxin therapy for leptomeningeal neoplasia.Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.
P2860
Q24564481-DFB529CB-658A-4D47-B7A4-945AA4CD19F9Q28078392-CBD8A8D8-C220-4369-B3E4-910B83D056ACQ30442764-C60AC492-F1DD-4018-90A5-476FA4C5D251Q35174521-57762652-A683-45E3-9588-ED474180D99AQ35352281-3230E634-5570-4AB5-B162-4EA4EA316A23Q35467267-9515DDEC-3C68-42A5-A32E-1BF15C6DD4E3Q35992824-55BFA151-2E9B-4CA2-B007-4E91ACC9F269Q36282608-92149B5F-8831-46AF-BCEB-F13886EA0A83Q36300286-555CD5B9-550F-4FB5-A93C-113953EFD5E5Q36346246-2EB8D7C9-3620-433A-9D29-942753B55A16Q36346564-FED811C5-9E93-44BA-B6E5-405F936816A3Q36346814-378D3DB8-FD58-465D-9ADA-F6C80C24C843Q36347048-F63C9032-D4FF-48C2-B6FE-00C464344606Q36347407-9B1ACA50-9902-437B-94A1-C4C1F8703975Q36347559-3930AAB1-0B8A-41EE-8D63-29D9B2729C20Q36364716-5E2B8D43-FCAC-468F-9A7D-23901A661165Q36384230-85609E77-0249-4C05-829F-A0B7E8E1E8B9Q37126006-F36D3276-9602-434E-A106-8564E41FFDB4Q37165245-7C46A8ED-7D9C-4544-9A66-BF2D51F91528Q37549734-84FEE4D5-82DF-4BD7-8D33-3C8A3F378582Q37602060-CF83FC49-51AC-42DC-881C-2E311A195A72Q38028653-E820BC32-6044-49B5-9B80-89B3886B9E4EQ38201457-010E69A3-6779-48B2-9160-35ECEB4F9B72Q39781466-51B418B5-E393-4A7C-A74A-5BE10E7A9239Q41149227-3AAC0EA1-6ED8-43F1-A0CE-61B215155F8FQ41505538-385B015F-C142-4657-965E-C688BC4898FFQ41506607-AB48DF33-9D0D-4675-BEEB-198A39A2FA61Q41848593-CBC4DCB0-CC1A-4521-927D-2221159B52CEQ42186665-4666F3D2-B900-44DE-AF8C-B658E66FA7B5Q48598762-D2A0849D-1DA8-479C-8E72-58C964473C72Q50962872-05EFA2EC-DA65-4787-BDA7-45DAC4CFB745
P2860
Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Selective killing of normal or ...... upled to the A chain of ricin.
@ast
Selective killing of normal or ...... upled to the A chain of ricin.
@en
type
label
Selective killing of normal or ...... upled to the A chain of ricin.
@ast
Selective killing of normal or ...... upled to the A chain of ricin.
@en
prefLabel
Selective killing of normal or ...... upled to the A chain of ricin.
@ast
Selective killing of normal or ...... upled to the A chain of ricin.
@en
P2093
P2860
P356
P1476
Selective killing of normal or ...... upled to the A chain of ricin.
@en
P2093
P2860
P304
P356
10.1073/PNAS.77.9.5419
P407
P577
1980-09-01T00:00:00Z